USFDA grants approval for generic Cyclosporine Soft Gel capsules

Cyclosporine is used as an immunosuppressant medication.

82
USFDA
Picture: Pixabay

Last Updated on August 5, 2022 by The Health Master

The United States Food & Drug Administration (USFDA) has approved cyclosporine soft gel capsules USP (Modified), 25 mg, 50 mg, and 100 mg, according to a statement released by Strides Pharma Science Limited (Strides), a step-down wholly owned subsidiary.

The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD), Neoral capsules 25 mg, 50 mg, and 100 mg, of Novartis Pharmaceuticals Corporation.

Cyclosporine soft gel capsules are part of Strides’ niche product portfolio with limited competition in the US market. Strides is the first Indian company to get approval for the product.

The approval further strengthens Strides immunosuppressant portfolio for the US markets which now comprises mycophenolate mofetil tablets and capsules, tacrolimus capsules, and cyclosporine soft gel capsules.

According to IQVIA MAT data, the US market for cyclosporine capsules USP, 25 mg, 50 mg, and 100 mg is approximately US$ 91 million.

The product will be manufactured at the company’s facility in Bengaluru and will be marketed by Strides Pharma Inc. in the US market.

The company has 279 cumulative ANDA filings (including the recently acquired portfolio from Endo at Chestnut Ridge) with the USFDA, of which 259 ANDAs have been approved and 20 are pending approval. The company has set a target to launch 20 new products every year in the US.

Cyclosporine is used as an immunosuppressant medication. It is prescribed for the prophylaxis of organ rejection in kidney, liver, and heart allogeneic transplants. The drug is also used to treat severe rheumatoid arthritis and psoriasis.

USFDA gives nod for Diclofenac Sodium Topical Gel

USFDA gives nod for generic birth control pills

USFDA gives nod for Belimumab to treat Paediatric Patients

USFDA gives nod for this generic high Blood Pressure drug

USFDA gives approval for this tablet to treat High BP

USFDA approves topical treatment addressing repigmentation

NPPA extends timeline for trade margin capping of these 5 Medical Devices

Modified PLI scheme to promote manufacturing of Bulk Drugs

USFDA issues Form 483 for 3 observations to Aurobindo Pharma

Govt releases new National Standards for Blood Centres and Blood Transfusion

Drug prices: What is One-molecule, One-price policy ?

USFDA completes inspection of Casper Pharma with Zero Observations

AYUSH doctors can practise allopathy with own system: High Court

7,700 drug samples declared not of standard quality

USFDA gives nod for Diclofenac Sodium Topical Gel

Latest Notifications regarding Pharmaceuticals

For informative videos by The Health Master, click on the below YouTube icon:

YouTube Icon
Telegram
WhatsApp
Facebook
LinkedIn
YouTube Icon
Google-news

Enter your email address:

Delivered by FeedBurner